Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma
Clinical trial NCT05635162 · RECRUITING
Trial details
- NCT number
- NCT05635162
- Sponsor
- University College, London
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-17
- Primary completion
- 2028-10-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.